We are live on
!
Find out more
SFM
Soros Fund Management Portfolio holdings
AUM
$9.12B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+30.69%
3 Year Est. Return
+70.05%
5 Year Est. Return
+69.93%
10 Year Est. Return
+534.14%
AUM
$6.02B
AUM Growth
-$1.63B
(-21%)
Cap. Flow
-$2.86B
Cap. Flow
% of AUM
-47.53%
Top 10 Holdings %
Top 10 Hldgs %
29.65%
Holding
274
New
78
Increased
32
Reduced
34
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$81.5M |
| 2 |
Aramark
ARMK
|
+$46.4M |
| 3 |
WRK
WestRock Company
WRK
|
+$39.3M |
| 4 |
Okta
OKTA
|
+$39.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$38.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$241M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$239M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$90.1M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$82.4M |
| 5 |
State Street SPDR EURO STOXX 50 ETF
FEZ
|
+$65.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.64% |
| 2 | Industrials | 7.12% |
| 3 | Financials | 5.45% |
| 4 | Communication Services | 5.11% |
| 5 | Consumer Discretionary | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Teledyne Technologies
TDY
$32B
| $4.39M | 0.07% |
10,216
+7,466
| +271% | +$3.2M |
|
127
Oneok
OKE
$54.5B
| $4.37M | 0.07% |
54,493
| – | – |
|
|
ALTM
128
DELISTED
Arcadium Lithium plc
ALTM
| $4.31M | 0.07% |
+1,000,000
| New | +$5.02M |
|
|
SLNO
129
DELISTED
Soleno Therapeutics
SLNO
| $4.28M | 0.07% |
+100,000
| New | +$4.52M |
|
130
Kenvue
KVUE
$36.9B
| $3.99M | 0.07% |
186,000
| – | – |
|
131
DigitalOcean
DOCN
$14.6B
| $3.99M | 0.07% |
+104,383
| New | +$3.88M |
|
132
State Street SPDR S&P Homebuilders ETF
XHB
$1.56B
| $3.91M | 0.06% |
+35,000
| New | +$3.5M |
|
133
Canadian Natural Resources
CNQ
$94.9B
| $3.82M | 0.06% |
+100,000
| New | +$3.34M |
|
134
iShares MSCI Canada ETF
EWC
$6.33B
| $3.74M | 0.06% |
97,700
| – | – |
|
135
Suncor Energy
SU
$70.3B
| $3.69M | 0.06% |
+100,000
| New | +$3.36M |
|
136
Western Midstream Partners
WES
$19.3B
| $3.36M | 0.06% |
94,550
| – | – |
|
137
AAR Corp
AIR
$5.76B
| $3.3M | 0.05% |
+55,153
| New | +$3.43M |
|
138
Albemarle
ALB
$15.5B
| $3.29M | 0.05% |
+25,000
| New | +$3.08M |
|
139
Lazard
LAZ
$4.31B
| $3.25M | 0.05% |
+77,700
| New | +$3.03M |
|
140
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $3.23M | 0.05% |
101,000
| – | – |
|
141
BP
BP
$107B
| $3.2M | 0.05% |
85,000
-85,000
| -50% | -$3.05M |
|
142
Sempra
SRE
$54.8B
| $3.16M | 0.05% |
44,000
-456,000
| -91% | -$32.7M |
|
143
Ambarella
AMBA
$3.81B
| $3.05M | 0.05% |
+60,000
| New | +$3.27M |
|
144
Chemours
CC
$2.37B
| $2.95M | 0.05% |
+112,348
| New | +$3.2M |
|
145
Global X Uranium ETF
URA
$6.22B
| $2.88M | 0.05% |
+100,000
| New | +$2.89M |
|
|
DX
146
Dynex Capital
DX
$3.21B
| $2.67M | 0.04% |
+214,626
| New | +$2.66M |
|
|
ECHO
147
EchoStar
ECHO
$26.2B
| $2.67M | 0.04% |
+187,383
| New | +$2.61M |
|
148
4D Molecular Therapeutics
FDMT
$562M
| $1.99M | 0.03% |
+62,500
| New | +$1.59M |
|
149
EQT Corp
EQT
$32.3B
| $1.85M | 0.03% |
+50,001
| New | +$1.79M |
|
|
ETRN
150
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $1.68M | 0.03% |
134,201
+1
| +0% | +$11 |
|
Similar funds
LCAM
VAS
A
HKAM
SUT
AI
AI
HI
Soros Fund Management's Q1 2024 Portfolio in Review
As of Q1 2024, Soros Fund Management held 274 positions worth $6.02B, down 21% from $7.65B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Soros Fund Management withdrew a net $2.86B in Q1 2024, closing 81 positions and reducing 34 holdings. Its most notable exit was Splunk Inc, an estimated $241M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5% a quarter earlier, followed by Industrials and Financials.
Against the trend, Soros Fund Management opened a new position in Cerevel Therapeutics Holdings, Inc. Common Stock worth $82M.
- Soros Fund Management's largest Q1 2024 buy was Cerevel Therapeutics Holdings, Inc. Common Stock: 1,940,201 shares worth $82M.
- Soros Fund Management added most to Aramark in Q1 2024, an estimated $46.4M increase.
- Soros Fund Management's biggest Q1 2024 reduction was Novo Nordisk, cutting an estimated $90.1M.
- Soros Fund Management fully exited Splunk Inc in Q1 2024, selling an estimated $241M.
- Soros Fund Management's ten largest holdings make up 30% of its $6.02B portfolio in Q1 2024.
- Soros Fund Management opened 78 new positions and closed 81 in Q1 2024.
- Soros Fund Management's portfolio value fell 21% quarter-over-quarter to $6.02B.
Based on Soros Fund Management's 13F filing for Q1 2024, filed 15 May 2024.